Medicine and Dentistry
Patient
100%
Lung Cancer
44%
Therapeutic Procedure
31%
Cells
29%
Lung
26%
Non Small Cell Lung Cancer
23%
Neoplasm
18%
Chemotherapy
16%
Small Cell Lung Cancer
15%
Diseases
14%
Hospital
14%
Inpatient
13%
Programmed Cell Death
13%
Specimen
13%
Surgery
12%
Combination Therapy
12%
Diagnosis
11%
Carboplatin
10%
Man
10%
Paclitaxel
9%
Survival Rate
9%
Protein P53
9%
Woman
9%
Prognosis
9%
Analysis
9%
Age
8%
Epithelial Cell
8%
Chest
8%
Computer Assisted Tomography
8%
Ligand
8%
Adenocarcinoma
8%
Tissues
8%
Idiopathic Pulmonary Fibrosis
8%
Serum
8%
Development
7%
Survival
7%
Cancer Registry
7%
Asthma
7%
Epidermal Growth Factor Receptor
7%
Smoking
6%
Protein
6%
Bleomycin
6%
Toxicity
6%
Association
6%
Clinical Trial
6%
Gene
5%
Blood
5%
Idiopathic Interstitial Pneumonia
5%
Programmed Death-Ligand 1
5%
Male
5%
Peptide
5%
Malignant Neoplasm
5%
Lesion
5%
Chronic Obstructive Pulmonary Disease
5%
Computed Tomography
5%
Metastatic Carcinoma
5%
Overall Survival
5%
Coughing
5%
Dyspnea
5%
Chemotherapeutic Agent
5%
Drug
5%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
35%
Non Small Cell Lung Cancer
23%
Chemotherapy
15%
Carboplatin
14%
Paclitaxel
14%
Toxicity
11%
Diseases
11%
Neoplasm
8%
Fibrosing Alveolitis
8%
Mouse
8%
Epidermal Growth Factor Receptor
7%
Cisplatin
7%
Respiratory Tract Allergy
7%
Docetaxel
6%
Gefitinib
6%
Lung Fibrosis
6%
Irinotecan
6%
Extravasation
6%
Malignant Neoplasm
6%
Protein P53
5%
Drug
5%
Erlotinib
5%
Peptide
5%
Neutropenia
5%
Epidermal Growth Factor Receptor Kinase Inhibitor
5%
Ozone
5%
Protein
5%
Pneumonia
5%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
8%
Nested Gene
8%
Smoking
7%
Genotyping
7%
Protein
7%
Association
6%
Mouse
5%
Cancer Cell
5%